Please login to the form below

Not currently logged in
Email:
Password:

personalised medicine

This page shows the latest personalised medicine news and features for those working in and with pharma, biotech and healthcare.

NICE unveils long-awaited review of methodologies

NICE unveils long-awaited review of methodologies

He added: “NICE is undertaking this review at a time of unprecedented change in the healthcare system, where developments such as personalised medicine, digitalisation of health, and use of cell and

Latest news

  • As Europe goes to polls, pharma seeks to keep healthcare, R&D a priority As Europe goes to polls, pharma seeks to keep healthcare, R&D a priority

    But if we truly pool all our knowledge and resources together, we can pursue ambitious goals so that, by combining prevention, early diagnosis and screening with personalised medicine, we could dramatically

  • Lynparza could soon add first line ovarian use in Europe Lynparza could soon add first line ovarian use in Europe

    As with other ‘personalised medicine’ drugs, the company’s commercial division is aiming to maximise uptake by broadening access to companion diagnostics which can identify BRCA mutations in patients across these

  • J&J’s targeted bladder cancer treatment gets US approval J&J’s targeted bladder cancer treatment gets US approval

    We’re in an era of more personalised or precision medicine, and the ability to target cancer treatment to a patient’s specific genetic mutation or biomarker is becoming the standard, ... Despite the first-to-market personalised medicine claim for

  • Going digital Going digital

    A new era, Medicine 2.0, is dawning too, where healthcare starts to harness the latest technology and the scope for personalised treatment grows. ... Personalised medicine means giving doctors and patients the abilities to adjust and calibrate treatment

  • Big opportunities in big data, but EMA and industry just getting started Big opportunities in big data, but EMA and industry just getting started

    The taskforce's visual representation of the Big Data roadmap. Respondents from large pharma tended to highlight personalised medicine, understanding current clinical care and informing clinical trial design as areas where

More from news
Approximately 10 fully matching, plus 105 partially matching documents found.

Latest Intelligence

  • AI is transforming pharma R&D – now it can transform pharma marketing AI is transforming pharma R&D – now it can transform pharma marketing

    As we move towards a future of personalised medicine, AI could assist in the identification of suitable patients for each therapy, helping HCPs construct tailored medicine regimes for patients. ... Conclusion. AI is evolving rapidly. The early adopters

  • Genomics integration: can the NHS rise to the challenge? Genomics integration: can the NHS rise to the challenge?

    With its potential in drug development, personalised medicine and transforming patient outcomes, the study of the human genome could address some of life sciences’ biggest challenges, including rising healthcare costs. ... We can then make sure

  • Cell and gene therapy Cell and gene therapy

    While manufacturing any medicine is a complex process, traditional therapies are manufactured through a linear process, from mass production to packaging and delivery to patients. ... For traditional biopharmaceutical products one batch equals many doses,

  • Cancer in The Information Age: are we illuminated or inundated? Cancer in The Information Age: are we illuminated or inundated?

    Personalised vs personal medicine. Data and information have already proved fruitful in the clinic, yielding the advent of personalised cancer medicine,. ... But for all the promise of personalised medicine, it can limit perspective, drawing clinical

  • The challenges of making genomics a reality for patients The challenges of making genomics a reality for patients

    It ushered in a new era of what we now call personalised medicine. ... To put this in context, developing the first cystic fibrosis medicine that treats the underlying cause took.

More from intelligence
Approximately 4 fully matching, plus 27 partially matching documents found.

Latest appointments

  • BMS appoints new commercial leader, Davies joins Eisai and more BMS appoints new commercial leader, Davies joins Eisai and more

    The field of genomic medicine has the potential to revolutionise our approach to rare genetic disease diagnosis and management, as well as in other areas of personalised medicine.”.

  • Stephen Eck joins Aravive Biologics Stephen Eck joins Aravive Biologics

    chairman of the board of directors of the Personalised Medicine Coalition.

  • FlowMetric Diagnostics names president FlowMetric Diagnostics names president

    It is a great time for the development of new flow cytometry-based companion diagnostics which can help advance personalised medicine and better meet the needs of physicians, healthcare workers and

  • GlobalData makes Americas appointment GlobalData makes Americas appointment

    Dr Bonnie Bain, global head of healthcare at GlobalData, adds: “Sean is widely recognised as an expert and thought leader in personalised and translational medicine, and it's great to welcome

  • Roche appoints new oncology research head Roche appoints new oncology research head

    Personalised cancer has been his forte, however, and he has served as director of personalised cancer medicine at Vanderbilt. ... I was particularly attracted to Roche as one of the pioneers and front-runners in personalised medicine, as the world's top

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 23 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you in the world of the patient...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics